Note that a well-known endogenous ligand of PPARγ 15d-PGJ2 did not affect cell viability (Fig. S2b), while unexpectedly, the PPARγ antagonist T0070907 reduced the cell viability of MES GBM (Fig. S2c). The gene discussed is PPARG; the disease is glioblastoma.